| The Concise Guide to PHARMACOLOGY 2019/20: G protein‐coupled receptors SPH Alexander, A Christopoulos, AP Davenport, E Kelly, A Mathie, ... British journal of pharmacology 176, S21-S141, 2019 | 742 | 2019 |
| THE CONCISE GUIDE TO PHARMACOLOGY 2015/16: G protein-coupled receptors SPH Alexander, AP Davenport, E Kelly, ... BRITISH JOURNAL OF PHARMACOLOGY 172 (24), 2015 | 571 | 2015 |
| Systemic human ILC precursors provide a substrate for tissue ILC differentiation AI Lim, Y Li, S Lopez-Lastra, R Stadhouders, F Paul, A Casrouge, ... Cell 168 (6), 1086-1100. e10, 2017 | 465 | 2017 |
| The Concise Guide to PHARMACOLOGY 2021/22: G protein‐coupled receptors SPH Alexander, A Christopoulos, AP Davenport, E Kelly, A Mathie, ... British journal of pharmacology 178, S27-S156, 2021 | 447 | 2021 |
| The concise guide to pharmacology 2017/18: overview SPH Alexander, E Kelly, NV Marrion, JA Peters, E Faccenda, SD Harding, ... British journal of pharmacology 174, S1-S16, 2017 | 310 | 2017 |
| The concise guide to PHARMACOLOGY 2015/16: Overview SPH Alexander, E Kelly, N Marrion, JA Peters, HE Benson, E Faccenda, ... British journal of pharmacology 172 (24), 5729-5743, 2015 | 242 | 2015 |
| A second cysteinyl leukotriene receptor in human lung. C Labat, JL Ortiz, X Norel, I Gorenne, J Verley, TS Abram, NJ Cuthbert, ... Journal of Pharmacology and Experimental Therapeutics 263 (2), 800-805, 1992 | 210 | 1992 |
| The role of prostaglandin E2 in human vascular inflammation I Gomez, N Foudi, D Longrois, X Norel Prostaglandins, Leukotrienes and Essential Fatty Acids 89 (2-3), 55-63, 2013 | 173 | 2013 |
| Prostanoid receptors in the human vascular wall X Norel The Scientific World Journal 7, 1359-1374, 2007 | 161 | 2007 |
| Specific inhibition of PAF-acether-induced platelet activation by BN 52021 and comparison with the PAF-acether inhibitors kadsurenone and CV 3988 D Nunez, M Chignard, R Korth, JP Le Couedic, X Norel, B Spinnewyn, ... European journal of pharmacology 123 (2), 197-205, 1986 | 158 | 1986 |
| Prostanoid receptors involved in the relaxation of human pulmonary vessels L Walch, C Labat, JP Gascard, V De Montpreville, C Brink, X Norel British journal of pharmacology 126 (4), 859-866, 1999 | 149 | 1999 |
| The Cyclooxygenase-2–Prostaglandin E2 Pathway Maintains Senescence of Chronic Obstructive Pulmonary Disease Fibroblasts M Dagouassat, JM Gagliolo, S Chrusciel, MC Bourin, C Duprez, ... American journal of respiratory and critical care medicine 187 (7), 703-714, 2013 | 121 | 2013 |
| Prostanoid receptors involved in the relaxation of human bronchial preparations X Norel, L Walch, C Labat, JP Gascard, E Dulmet, C Brink British journal of pharmacology 126 (4), 867-872, 1999 | 97 | 1999 |
| M1 and M3 muscarinic receptors in human pulmonary arteries. X Norel, L Walch, M Costantino, C Labat, I Gorenne, E Dulmet, F Rossi, ... British journal of pharmacology 119 (1), 149, 1996 | 97 | 1996 |
| Prostanoid EP1‐ and TP‐receptors involved in the contraction of human pulmonary veins L Walch, V De Montpreville, C Brink, X Norel British journal of pharmacology 134 (8), 1671-1678, 2001 | 96 | 2001 |
| The muscarinic receptor subtypes in human blood vessels. L Walch, C Brink, X Norel Therapie 56 (3), 223-226, 2001 | 91 | 2001 |
| Vasorelaxation induced by prostaglandin E2 in human pulmonary vein: role of the EP4 receptor subtype N Foudi, L Kotelevets, L Louedec, G Leseche, D Henin, E Chastre, ... British journal of pharmacology 154 (8), 1631-1639, 2008 | 87 | 2008 |
| Human perivascular adipose tissue dysfunction as a cause of vascular disease: focus on vascular tone and wall remodeling G Ozen, A Daci, X Norel, G Topal European journal of pharmacology 766, 16-24, 2015 | 77 | 2015 |
| PGE2 receptor (EP4) agonists: Potent dilators of human bronchi and future asthma therapy? C Benyahia, I Gomez, L Kanyinda, K Boukais, C Danel, G Leséche, ... Pulmonary pharmacology & therapeutics 25 (1), 115-118, 2012 | 73 | 2012 |
| Degradation of acetylcholine in human airways: role of butyrylcholinesterase. X Norel, M Angrisani, C Labat, I Gorenne, E Dulmet, F Rossi, C Brink British journal of pharmacology 108 (4), 914, 1993 | 69 | 1993 |
